Hellman & Friedman Capital Partners X (Parallel), L.P.

Hellman & Friedman Capital Partners X (Parallel), L.P. insider trades: Medline (MDLN) stock sales

Medline Last trade Mar 10, 2026 4 Form 4 filings
$1.23B
Sold, last 12 months
7 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Hellman & Friedman Capital Partners X (Parallel), L.P. reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 10, 2026MDLN↓ Sell$593.0M
Mar 10, 2026MDLN↓ Sell$397.0M
Mar 10, 2026MDLN↓ Sell$42.9M
Mar 10, 2026MDLN↓ Sell$25.5M
Dec 18, 2025MDLN↓ Sell$144.1M
Dec 18, 2025MDLN↓ Sell$15.5M
Dec 18, 2025MDLN↓ Sell$13.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MDLN insiders

Open-market trades in the last 12 months

About Hellman & Friedman Capital Partners X (Parallel), L.P.'s insider trades

Hellman & Friedman Capital Partners X (Parallel), L.P. is an insider at Medline (MDLN). Since Dec 18, 2025, it has reported no open-market purchases and 7 sales worth $1.23B on SEC Form 4. In the last 12 months: 7 sales ($1.23B).

Its filings also include other transactions (4 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.